Results 51 to 60 of about 92,597 (264)

DETERMINAN PENGUNGKAPAN VARIASI PERTUMBUHAN LABA ANTAR SEGMEN

open access: yesJurnal Akuntansi Kontemporer, 2020
The results of previous studies regarding the determinants of strategic revelation of differences in segmen earnings growth are still not consistent.
Natalia Christine Putri, Lodovicus Lasdi
doaj   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

STRATEJİK MALİYET YÖNETİMİ ENSTRÜMANI OLARAK PAZARA DAYALI HEDEF MALİYET YÖNETİMİ-PDHMY

open access: yesSosyal Ekonomik Araştırmalar Dergisi, 2002
Ürün geliştirmenin ilk safhasında pazara dayalı maliyet yönetiminin önemli bir enstrümanı olan PDHMY, ürün fiyatını geleneksel Maliyet + Kar = Fiyat anlayışından farklı bir biçimde Fiyat – Kar = Maliyet anlayışına göre pazara dayalı olarak ...
Yunus Ceran
doaj   +2 more sources

Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer

open access: yesFEBS Open Bio, EarlyView.
A novel signature integrating genome‐wide analysis with clinical factors predicts recurrence in stage II colorectal cancer and enables a new risk stratification to guide postoperative adjuvant chemotherapy. Clinical risk stratification for postoperative recurrence in patients with pathological stage II (pStage II) colorectal cancer (CRC) is essential ...
Mayuko Otomo   +7 more
wiley   +1 more source

MagmaFlow: A desktop platform for artificial intelligence‐driven expression analysis

open access: yesFEBS Open Bio, EarlyView.
MagmaFlow is a free, no‐code platform for gene expression analysis. It generates interactive volcano plots, links genes to literature, pathways, and diseases, prioritizes candidates using millions of publications, identifies affected biological processes, builds network diagrams, and exports publication‐ready figures and reports for macOS and Windows ...
Carlos E. Buss   +7 more
wiley   +1 more source

DUAL NATURE OF INDUSTRIAL ENTERPRISE COST MANAGEMENT SYSTEM

open access: yesBaltic Journal of Economic Studies, 2019
The research subject is the cost management system of an industrial enterprise. The purpose of the article is the theoretical substantiation of the methodical aspects of the cost management system as a part of the industrial enterprise management system.
Natalia Radionova   +2 more
doaj   +1 more source

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

open access: yesAging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel   +4 more
wiley   +1 more source

Value Analysis, Value Engineering and Value Management in Global Competition

open access: yesSymphonya
Cost analysis is a method to enhance the costs efficiency by evaluating the corporate profitability. In today business environment of global competition, war pressures, new markets and demographics, firms are changing their approach to cost control.
Silvio M. Brondoni
doaj   +1 more source

Home - About - Disclaimer - Privacy